Learning Objectives: Upon finishing this course, the participants will be able to
A. Differentiate the mimickers of acute lung injury.
B. Review the next generation sequencing reports on lung cancer.
C. Differentiate the immunohistochemical features of various lung cancers.
D. Recognize reimbursement, administrative and malpractice concerns for lung cancer diagnosis.
Target Audience: Pathologists, Physicians, Surgeons and other Allied Health Professionals

Handouts (password protected, only accessible to the meeting attendees)
How to download? Click the links below, and the download will start immediately. OR you may hover your mouse over the link, right click the mouse, and then choose “save as” to save the file to the location of your desire.
The file sizes are large. Caution should be used while downloading with your wireless/mobile devices and their data plan.
Part I , size 7.7M
Part II, size 10.1M
Part III, size 8.7M

Meeting Date: Saturday, May 14, 2016
RSVP: Saturday April 30, 2016 (Registration link)
Location: Conference room C-E, 1 FL Education Building, PHCS (see Venue and Directions)

Course Faculty
8:25- 8:30 am Opening Remarks by the Program Directors: Lanjing “L.J.” Zhang, MD, MS, at PHCS/Rutgers University and Philip T. Cagle, MD at Houston Methodist Hospital/ Weill Cornell Medical College
8:30-9:00 am Pulmonary in-vivo microscopy by Lida Hariri, MD, PhD at MGH/Harvard University
9:00-9:30 am The shifting role of pathology in a consensus driven classification of diffuse interstitial lung diseases by Jeffrey Myers, MD at University of Michigan
9:30-10:00 am What pathologists should know about cryobiopsy in patients with Interstitial lung disease by Thomas V. Colby, MD at Mayo Clinic
Morning break 10:00-10:30 am
10:30-11:00 am Difficult areas in lung cancer staging by Sanja Dacic, MD, PhD at University of Pittsburgh
11:00-11:30 am Reimbursement, administrative, and malpractice concerns for current lung cancer diagnosis by Timothy C. Allen, MD, JD at UTMB
11:30-12:00 pm Update on the robotic-assisted surgery for thoracic malignancies by John Heim, MD at PHCS/Rutgers University
Lunch break 12:00-1:00 pm
1:00-1:30 pm Interstitial pneumonia with autoimmune features: The next big thing in Interstitial Lung disease by Kevin O. Leslie, MD at Mayo Clinic
1:30-2:00 pm Interpretation of NGS reports by Lynette Sholl, MD at BWH/Harvard University
2:00-2:30 pm Update on immunohistochemistry in lung cancer diagnosis by Natasha Rekhtman, MD, PhD at Memorial Sloan Kettering Cancer Center
Afternoon break 2:30-2:45 pm
2:45-3:15 pm Differential diagnosis of acute lung injury by Mary Beth Beasley, MD at The Icahn School of Medicine at Mount Sinai
3:15-3:45 pm Frozen section pitfalls in thoracic pathology by Alain C. Borczuk, MD at Weill Cornell Medicine
3:45-5:00 pm Networking session

Princeton HealthCare System is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Princeton HealthCare System designates this live activity for a maximum of five and a half (5.5) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have a disability that may require special assistance, please contact Janis Puleio, CME Coordinator at (609) 853-7450.

Sponsors
Bristol-Myers Squibb
Foundation Medicine
Princeton HealthCare System
New Jersey Institute of Medicine
QuanDx

Non-Financial Sponsors
College of American Pathologists
Pulmonary Pathology Society